Evidence map›Paper›PMID 40594300›Full record

ArticleScientific reports2025

Correlation of

Jian-Gong Shi, Yan Li, Qing-Hua Mu, Ji-Ming Zhao, Yan-Bing Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jian-Gong ShiDepartment of Nuclear Medicine, Rizhao People's Hospital, Rizhao, 276800, Shandong, China.
Yan LiDepartment of Nuclear Medicine, Rizhao People's Hospital, Rizhao, 276800, Shandong, China.
Qing-Hua MuDepartment of Nuclear Medicine, Rizhao People's Hospital, Rizhao, 276800, Shandong, China.
Ji-Ming ZhaoDepartment of Nuclear Medicine, Rizhao People's Hospital, Rizhao, 276800, Shandong, China.
Yan-Bing WangDepartment of Nuclear Medicine, Rizhao People's Hospital, Rizhao, 276800, Shandong, China. mengbinrz@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to evaluate the correlation between positron emission tomography/computed tomography (PET/CT) parameters and the degree of proliferation of lung adenocarcinoma. A retrospective analysis was conducted on 50 patients who had undergone surgical treatment for lung adenocarcinoma and had been subsequently diagnosed pathologically. The general clinical characteristics of the subjects were documented, and the presurgical 2-deoxy-2-fluorine-18-fluoro-D-glucose

Indexed as

AdenocarcinomaAdenocarcinoma of LungFluorodeoxyglucose F18Lung NeoplasmsPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overCell ProliferationFemaleHumansKi-67 AntigenMaleMiddle AgedRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18Ki-67 AntigenRadiopharmaceuticalsAdenocarcinoma of lungKi-67 antigenPositron-emission tomography

Identifiers

PMID40594300
PMCPMC12215422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.